Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options.
about
Prospecting for novel plant-derived molecules of Rauvolfia serpentina as inhibitors of Aldose Reductase, a potent drug target for diabetes and its complicationsProstaglandin E1 for preventing the progression of diabetic kidney diseaseMolecular docking and structure-based drug design strategiesProtein glutathionylation in cardiovascular diseasesElectrostatic Fields near the Active Site of Human Aldose Reductase: 2. New Inhibitors and Complications Caused by Hydrogen BondsPartial inhibition of aldose reductase by nitazoxanide and its molecular basisA potential therapeutic role for aldose reductase inhibitors in the treatment of endotoxin-related inflammatory diseasesRedox activation of aldose reductase in the ischemic heartAldose reductase deficiency protects sugar-induced lens opacification in ratsTwenty-five years since the discovery of endothelium-derived relaxing factor (EDRF): does a dysfunctional endothelium contribute to the development of type 2 diabetes?Cross-linking protein glutathionylation mediated by O2-arylated bis-diazeniumdiolate "Double JS-K".Inhibition of aldose reductase prevents colon cancer metastasisInhibition of aldose reductase prevents experimental allergic airway inflammation in mice.Aldo keto reductase 1B7 and prostaglandin F2alpha are regulators of adrenal endocrine functions.Structure based comprehensive modelling, spatial fingerprints mapping and ADME screening of curcumin analogues as novel ALR2 inhibitors.Aldose reductase inhibition prevents metaplasia of airway epithelial cells.Aldose reductase regulates vascular smooth muscle cell proliferation by modulating G1/S phase transition of cell cycle.Ellagic acid, a new antiglycating agent: its inhibition of Nϵ-(carboxymethyl)lysine.Postischemic deactivation of cardiac aldose reductase: role of glutathione S-transferase P and glutaredoxin in regeneration of reduced thiols from sulfenic acidsPosttranslational glutathiolation of aldose reductase (AKR1B1): a possible mechanism of protein recovery from S-nitrosylation.Inhibition of aldose reductase prevents growth factor-induced G1-S phase transition through the AKT/phosphoinositide 3-kinase/E2F-1 pathway in human colon cancer cellsAldose reductase inhibition suppresses the expression of Th2 cytokines and airway inflammation in ovalbumin-induced asthma in mice.Diabetic nephropathy - complications and treatment.Reduction of Melatonin Level in Patients with Type II Diabetes and Periodontal DiseasesPolyol pathway impairs the function of SERCA and RyR in ischemic-reperfused rat hearts by increasing oxidative modifications of these proteins.ALDOSE REDUCTASE: New Insights for an Old Enzyme.A new approach to control the enigmatic activity of aldose reductase.Aldose reductase inhibition suppresses airway inflammation.Aldose reductase inhibition suppresses oxidative stress-induced inflammatory disorders.Ocular complications of diabetes mellitus.Aldose reductase inhibition prevents hypoxia-induced increase in hypoxia-inducible factor-1alpha (HIF-1alpha) and vascular endothelial growth factor (VEGF) by regulating 26 S proteasome-mediated protein degradation in human colon cancer cellsA clinical and neuropathological study of Chinese patients with diabetic peripheral neuropathy.Targeting aldose reductase for the treatment of cancerTranscriptional and post-translational modulation of myo-inositol oxygenase by high glucose and related pathobiological stresses.Amelioration of experimental autoimmune uveoretinitis by aldose reductase inhibition in Lewis ratsAldose reductase deficiency protects from autoimmune- and endotoxin-induced uveitis in mice.Reductive metabolism increases the proinflammatory activity of aldehyde phospholipidsAldose reductase deficiency in mice protects from ragweed pollen extract (RWE)-induced allergic asthma.Role of aldo-keto reductase enzymes in mediating the timing of parturitionOsmolarity and glucose differentially regulate aldose reductase activity in cultured mouse podocytes.
P2860
Q21133564-8BD51D95-5843-4F59-860D-B66ADB813DADQ24235251-8EB64A05-D67A-409C-A181-356B59F0BC3BQ26800097-5F2184F4-255E-405E-9452-95BF7CE7E4E8Q27009841-D996B370-FB24-4EFA-9777-F49BFA9AD804Q27671897-94561B88-80C2-4C8C-8C20-1086F646262CQ27681971-E41BA39C-51B3-4B48-A5D8-CA431392C1D0Q28382891-45617828-168A-4FBB-A0BA-EA9C2699F7E3Q28564820-EFF5916B-D4FC-428A-AC85-D3EA2F0DCCAEQ28566633-06840D50-9759-416D-B477-A95FD988794AQ30352122-D952ABA1-AD86-4223-A18C-52B4AC12DA9EQ30422929-633D7D37-1FF3-464C-B495-D49803C7D44CQ30503931-B9EC21BD-32DF-4CC3-A87F-B5629A53A25AQ33490994-E3B28526-4362-4077-866E-24B334B0A108Q33509010-BCF5EB4B-91A9-4E01-BADC-15BD791FBC69Q33554440-60E2C422-2210-4DD6-BA0C-0D5F9222693EQ33784428-9F2D84AD-7316-4EAC-AD7E-BD352C63856DQ33848283-CE51529C-159E-4198-9FBE-978FC77BFCD6Q34068791-670D03E2-7E34-4CFE-B42F-FA220BF02DE6Q34074329-B5AA16B8-334F-42E9-B455-301282B960F4Q34090284-5D6652CB-59DA-464D-AE62-B51D3661DD49Q34159639-E57DC540-64C7-4891-9AD3-E55B67DB3EBEQ34206747-468159A4-597E-4F4B-AC39-7D6BC0A78C42Q34387952-22CAFCCB-C2FB-4434-AE04-CE9EE03D966EQ34389915-BFD6FAF4-CDEE-49FF-8B40-98AB7B645858Q34595686-3E2BB862-1FBD-4061-A62F-610EF33C95F2Q34895688-744011C0-7D8A-4192-A20C-53A3B71BDA94Q34982833-E5701090-3486-49AE-B17D-BEE5D1C84298Q35011968-70C83249-3659-430A-8FD0-5DA0B5794024Q35012014-329E86DC-6AD0-478A-BBC0-9C0641186733Q35049903-9DA9269E-4AA9-4B70-9D31-F9BE8483F1F1Q35085094-C48CD058-B526-4BF9-879A-2CE0174ED87FQ35117968-F408B6E0-C764-4E95-863D-E5B706F04A2DQ35125587-6E6D0B35-7C1E-43D1-912A-7C31E5798707Q35144977-DFEECD9C-DF83-4B71-8CDD-11DF581300C0Q35522151-256281DB-6901-418F-9583-41BBB10F64D8Q35522227-59C7CA62-3EED-4333-A91C-E6A7A5E6C6D7Q35561973-2E5BC746-F668-4454-A4EF-01D953CDDB30Q35600403-063B6A50-92B4-4C8E-B2EF-C3555559CB1FQ35660367-901B7938-62E1-4F6D-BA0F-9843788D7A05Q35664105-818A301B-2651-471E-B34E-0FE0FB94484F
P2860
Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options.
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Role of aldose reductase and o ...... ntial for therapeutic options.
@ast
Role of aldose reductase and o ...... ntial for therapeutic options.
@en
Role of aldose reductase and o ...... ntial for therapeutic options.
@nl
type
label
Role of aldose reductase and o ...... ntial for therapeutic options.
@ast
Role of aldose reductase and o ...... ntial for therapeutic options.
@en
Role of aldose reductase and o ...... ntial for therapeutic options.
@nl
prefLabel
Role of aldose reductase and o ...... ntial for therapeutic options.
@ast
Role of aldose reductase and o ...... ntial for therapeutic options.
@en
Role of aldose reductase and o ...... ntial for therapeutic options.
@nl
P356
P1433
P1476
Role of aldose reductase and o ...... ntial for therapeutic options.
@en
P2093
Aruni Bhatnagar
Satish K Srivastava
P304
P356
10.1210/ER.2004-0028
P577
2005-04-06T00:00:00Z